The Depo Provera lawsuit is one of the fastest growing pharmaceutical cases in the United States right now. Over 3,490 cases are pending in federal court as of April 2026, and the first trial is scheduled for December 2026.
If you used Depo-Provera and were diagnosed with a meningioma brain tumor, this article covers everything you need to know. That includes settlement estimates, eligibility requirements, court milestones, and how to file.Around 24.5% of all sexually active women in the U.S. have used Depo-Provera at so me point. That is a staggering number of people who may be affected by this litigation.
You’ll find real numbers, specific dates, and practical answers below. No fluff. No filler. Just facts that could affect your life and your legal options.
Depo Provera Lawsuit 2026: Where Things Stand Right Now
The Depo Provera lawsuit in 2026 is in an active pretrial phase with major rulings expected this summer. The Depo-Provera MDL 3140 is in the District Court for the Northern District of Florida, and as of April 2026, 3,490 cases were pending before Judge M. Casey Rodgers.
This litigation has exploded in size over the past 12 months. From February 2026 to March 2026, the Depo shot lawsuit saw an increase of 1,001 cases, a 47.7% jump in one month. From March 2025 to March 2026, the litigation grew from 78 to 3,099 cases, a 3,873% increase in just one year. The case is now entering a phase focused on the scientific evidence linking Depo-Provera to meningioma brain tumors, with expert depositions on general causation underway and scheduled through March 20, and Daubert motions to be fully briefed by May 29.
As of March 2026, plaintiffs’ lawyers report holding onto nearly 10,000 unfiled claims. That means thousands more cases could flood the docket in the months ahead.
| Detail | Status |
|---|---|
| MDL Number | 3140 |
| Judge | M. Casey Rodgers |
| Court | Northern District of Florida |
| Total Cases (April 2026) | 3,490 |
| Total Plaintiffs | 3,790 |
| First Trial Date | December 2026 |
| Next Major Hearing | Daubert Hearings, June 2026 |
Depo Provera Lawsuit Settlement Amounts: What Could You Get?
No global settlement has been announced yet in the Depo Provera litigation. There have been no substantive moves toward settling individual cases or offering a global settlement so far, as of early 2026.
That said, attorneys are already projecting ranges. Lawyers estimate that individual Depo-Provera lawsuit settlement amounts could range between $100,000 and $500,000 or more, depending on individual circumstances.
For the most serious cases, the numbers could climb much higher. Settlements might range between $100,000 and $500,000 for smaller, treatable meningiomas with limited life impact. For large, debilitating tumors with extensive medical treatment and significant life impact, settlements or verdicts could range from $1 million to $5 million or more. In other lawsuits involving meningiomas, settlement payouts have averaged more than $800,000, and jury verdicts have exceeded $3 million, according to the National Library of Medicine.
Think of it like a tiered system. Small tumors with minimal impact sit at one end. Life-altering diagnoses with multiple surgeries sit at the other.
| Settlement Tier | Estimated Range | Typical Case Profile |
|---|---|---|
| Tier 1 (Severe) | $1M to $5M+ | Large tumor, surgery, permanent disability |
| Tier 2 (Moderate) | $300K to $1M | Surgery required, lasting symptoms |
| Tier 3 (Lower) | $100K to $300K | Smaller tumor, monitoring, limited impact |
Is There a Depo Provera Class Action Lawsuit?
There is not a traditional Depo Provera class action lawsuit. Instead, most federal cases have been consolidated into a Multidistrict Litigation, or MDL, which is a procedural mechanism used to manage a large number of individual lawsuits that involve common factual questions.
The distinction matters for your wallet. In a class action, one or several representative plaintiffs pursue a single case on behalf of an entire group, and any settlement or verdict typically applies uniformly to all class members. In an MDL, each plaintiff files an individual lawsuit, and while pretrial proceedings are handled together, every person maintains their own claim, injury profile, and potential damages.
This is good news for claimants with severe injuries. Your payout isn’t averaged with everyone else’s. Your case is your case.
A newly filed Depo-Provera class action lawsuit has been filed seeking medical monitoring for individuals who used Depo-Provera for over a year and face an increased risk of developing intracranial meningiomas. So there is a class action track, but it’s focused on monitoring, not individual injury payouts.
- MDL: Individual lawsuits grouped for pretrial efficiency. Payouts vary per person.
- Class Action: One representative case. Uniform payout for all members.
- Current Structure: The brain tumor claims are in the MDL. The medical monitoring case is a class action.
Key Takeaway: The Depo Provera litigation has over 3,490 active MDL cases, projected individual settlements of $100,000 to $5 million, and the first trial is set for December 2026.
Depo Provera Brain Tumor Lawsuit Explained
The Depo Provera brain tumor lawsuit centers on one core claim: Pfizer failed to warn women that the birth control shot could cause meningioma brain tumors. Depo-Provera lawsuits are product liability lawsuits filed against Pfizer and other drug companies by women who developed brain or spinal tumors after using the birth control shot. The lawsuits allege that manufacturer Pfizer failed to warn users about an increased risk of developing meningioma brain tumors.
A meningioma grows in the membranes surrounding the brain and spinal cord. Meningiomas are the most common type of brain tumor, accounting for about 40 percent of reported brain tumors. While many meningiomas are benign, they can still cause serious neurological symptoms depending on size and location.
The first Depo-Provera brain tumor lawsuit was filed on October 1, 2024. On that date, Kristina Schmidt filed suit in the United States District Court of Northern California with nine allegations against Pfizer, Inc. and its co-defendants. Schmidt contends that Pfizer did not adequately warn that their Depo-Provera contraceptive may cause the development of intracranial meningioma.
Since then, the wave of filings has been relentless. Women from Texas, New Jersey, Tennessee, Indiana, Nevada, and California have all joined.
Depo Provera Meningioma Lawsuit: The Science Behind the Claims
The scientific evidence supporting the Depo Provera meningioma lawsuit is strong and growing. A 2024 study in The British Medical Journal found that women who used Depo-Provera for more than a year faced a 5.6 times higher risk of developing meningiomas compared to non-users.
That’s not a small bump in risk. That’s a 5.6x increase. Imagine being told your favorite daily vitamin increased heart attack risk by that much. You’d want to know, right? In a new study that examined over 61 million female patient records, women who used DMPA, the generic name for Depo-Provera, had a two-times higher risk of getting diagnosed with meningioma compared to women not on hormonal birth control. Studies linking Depo-Provera to meningioma go back to 1983, when researchers discovered that synthetic hormones could stimulate progesterone receptors in these tumors. Pfizer had decades of warning signs.
- BMJ 2024 Study: 5.6x increased meningioma risk for users of 1+ year
- Cleveland Clinic Study (2025): 2.45x increased risk for long-term users
- 1983 Research: First evidence that synthetic hormones stimulate meningioma growth
- FDA Label Update (December 2025): Meningioma warning officially added
Pfizer Depo Provera Lawsuit: Why Pfizer Is the Target
Pfizer is the primary defendant because it manufactures and markets brand-name Depo-Provera. Pfizer is the main defendant in the Depo-Provera litigation. Generic manufacturers A-S Medication Solutions, Greenstone LLC, Pharmacia & Upjohn Company LLC, Prasco Laboratories and Preferred Pharmaceuticals Inc. are also named.
The allegations against Pfizer boil down to a pattern of concealment.
At the center of every lawsuit is the same core accusation: Pfizer knew about the brain tumor risk for years and said nothing. Years ago, Canada and the European Union added a warning about the potential link between Depo-Provera and meningiomas. However, users in the U.S. weren’t given the same warning until a label update in December 2025.Pfizer has a real uphill climb arguing a lack of causation when it now has a warning on the product for that very same risk.
Pfizer’s defense strategy relies on federal preemption. The order confirms that if Pfizer wins on preemption, the MDL essentially ends. But the December 2025 FDA label change severely damaged that argument.
| Defendant | Role |
|---|---|
| Pfizer Inc. | Brand-name manufacturer |
| Greenstone LLC | Generic manufacturer |
| Pharmacia & Upjohn Company LLC | Pfizer subsidiary |
| A-S Medication Solutions | Generic distributor |
| Prasco Laboratories | Generic manufacturer |
| Preferred Pharmaceuticals Inc. | Generic manufacturer |
Key Takeaway: Pfizer knew about the meningioma risk for decades, and the December 2025 FDA label change punched a hole in the company’s main legal defense.
Who Qualifies for the Depo Provera Lawsuit?
You may qualify for the Depo Provera lawsuit if you used the birth control shot and were later diagnosed with a meningioma. To qualify, you must prove you used Depo-Provera, Depo-SubQ Provera or an authorized generic version, and then developed a meningioma.
You may qualify to file a Depo shot lawsuit if you or a loved one used Depo-Provera, Depo-SubQ Provera 104, or authorized generics for over a year; developed a type of brain or spine tumor known as a meningioma; or underwent surgery or radiation or have these treatments scheduled for the future.
You may not qualify if you took the shot only once or if you developed a brain tumor before your first injection.
Some attorneys set a minimum threshold.
Some law firms may require your diagnosis to be 24 months after your first Depo injection.
Quick Eligibility Checklist:
- Used Depo-Provera, Depo-SubQ Provera 104, or a generic version
- Received at least two injections
- Diagnosed with an intracranial meningioma after starting the drug
- Tumor required surgery, radiation, or ongoing monitoring
- Within your state’s statute of limitations
Depo Provera Lawsuit Symptoms to Watch For
Meningioma symptoms linked to the Depo Provera lawsuit often develop gradually over months or years. These tumors typically grow slowly and may remain symptom free for years. Because meningiomas expand gradually, they often go unnoticed until they press on nearby tissue, causing symptoms to emerge and delaying diagnosis. Plaintiffs have reported developing “painful and disturbing” symptoms, including headaches, dizziness, vertigo, insomnia, and irritability.
One plaintiff experienced hearing loss and a feeling of fullness in her ear. After experiencing side effects such as constant dizziness, extreme fatigue, and chronic incontinence, one plaintiff underwent surgery in July 2017 to remove a large meningioma.
Commonly reported symptoms in Depo Provera lawsuits:
- Persistent or worsening headaches
- Dizziness and vertigo
- Vision changes or loss
- Hearing loss or ear fullness
- Seizures
- Memory problems
- Arm or leg weakness
- Speech difficulties
- Chronic fatigue
- Insomnia and irritability
If you used Depo-Provera for more than a year and recognize these symptoms, that combination is exactly what attorneys are looking for.
Depo Provera Lawsuit Side Effects Beyond Brain Tumors
The Depo Provera lawsuit focuses primarily on meningioma, but this drug has a wider history of side effect concerns. The most recent Depo-Provera lawsuits are for brain tumors, but earlier Depo-Provera litigation involved claims for pseudotumor cerebri and loss of bone mineral density.
In a prior Canadian class action, Pfizer paid $1,913,750 to the class and $262,500 to health insurance companies to settle bone density claims in 2021. Depo-Provera pseudotumor cerebri lawsuits claimed the birth control shot could cause a condition that occurs when pressure builds up in the brain, mimicking a tumor.
That said, the current MDL is limited to meningioma claims. Only Depo-Provera users who developed meningiomas are currently eligible to join the MDL. Other side effect claims exist, but they are handled separately.
| Side Effect | Lawsuit Status |
|---|---|
| Meningioma brain tumors | Active MDL, 3,490+ cases |
| Bone mineral density loss | Prior Canadian class action settled |
| Pseudotumor cerebri | No significant settlements to date |
| Other brain tumor types | Not currently included in MDL |
Key Takeaway: The current MDL only covers meningioma brain tumors, but Depo-Provera has a longer history of side effect lawsuits, including bone loss and pseudotumor cerebri.
Depo Provera MDL Update 2026: Key Court Milestones
The Depo Provera MDL is moving at an unusually fast pace for pharmaceutical litigation. On March 11, Judge Rodgers issued Case Management Order (CMO) 11 for the Depo-Provera MDL, which shared several important litigation updates. As of March 6, 2026, there are 3,790 unique plaintiffs in this litigation.
Two major legal battles are playing out right now. The court confirmed that if Pfizer wins on preemption, the MDL essentially ends. But if Pfizer loses, the case moves directly into Rule 702 hearings on general causation, already scheduled for late May 2026. The judge overseeing the Depo-Provera lawsuits has rescheduled the causation hearings to June 24 through June 26, 2026. The judge has selected five pilot cases for the MDL to be the first cases tried.
2026 MDL Timeline:
| Date | Milestone |
|---|---|
| March 2026 | CMO 11 issued; expert depositions ongoing |
| April 17, 2026 | Case Management Conference |
| May 15, 2026 | Next scheduled CMC |
| May 29, 2026 | Daubert motions fully briefed |
| June 24 to 26, 2026 | General causation hearings |
| December 2026 | First bellwether trial |
Depo Provera Bellwether Trial 2026: What It Means for You
The first Depo Provera bellwether trial is set for December 2026, and its outcome will shape the entire litigation. The first trial is expected to begin in December 2026.
Bellwether trials are test cases. The court picks a handful of representative plaintiffs and sends their cases to a jury. These trials are designed to gauge jury reactions and often play a key role in shaping settlement discussions. One woman’s case is one of 5 selected as test trials that will likely impact all cases in the Depo-Provera litigation. Her story involves using Depo-Provera for 20 years and being diagnosed with two meningiomas. If Judge Rodgers is satisfied with the causation evidence in June, the December bellwether trials become the next major pressure point. Strong plaintiff verdicts there would accelerate settlement talks considerably.
If Pfizer loses the bellwether trial, settlement negotiations could start in early 2027. If Pfizer wins, it could delay payouts significantly. Either way, December 2026 is the date everyone is watching.
- 5 pilot cases selected by Judge Rodgers
- December 2026 trial date confirmed
- A plaintiff verdict could trigger settlement negotiations
- A defense verdict could delay the process by years
Depo Provera Lawsuit Statute of Limitations by State
The statute of limitations for the Depo Provera lawsuit varies by state, generally ranging from 1 to 6 years. The statute of limitations on Depo-Provera brain tumor claims is between 1 and 6 years, depending on the state.
Here is the key nuance. The discovery rule is a legal principle that delays the start of the statute of limitations until a plaintiff knows, or reasonably should know, about both the injury and its connection to the defendant’s conduct. In the context of Depo-Provera meningioma lawsuits, women who developed brain tumors could not have reasonably suspected the link between their condition and Depo-Provera until recent scientific studies were published.
This means lawsuits are still being filed, even by women who last used Depo-Provera many years ago. Equitable tolling can extend the time to file a lawsuit if a defendant’s misconduct or concealment delayed the plaintiff’s awareness. The plaintiffs’ lawsuits against Pfizer will rely on equitable tolling by arguing that the company intentionally withheld information about the risks.
| State Category | Typical Filing Window | Notes |
|---|---|---|
| Short deadline states | 1 to 2 years | Discovery rule may extend |
| Moderate deadline states | 2 to 3 years | Most common range |
| Longer deadline states | 4 to 6 years | More time, but don’t wait |
The bottom line: even if you used Depo-Provera decades ago, you may still have a valid claim. But the window won’t stay open forever.
Key Takeaway: Most women who act now should not face statute of limitations problems, thanks to the discovery rule and the fact that the Depo-Provera and meningioma link only became widely known recently.
How to File a Depo Provera Lawsuit Step by Step
Filing a Depo Provera lawsuit starts with a free case review from a product liability attorney. Once all of the necessary evidence is collected, your attorney will draft and file a legal complaint against the manufacturer of Depo-Provera. An attorney can help ensure that your complaint is filed in the appropriate court and meets all legal requirements.All plaintiffs in the Depo-Provera MDL must complete a Use/Injury Questionnaire and submit supporting documentation through the BrownGreer MDL Centrality system. Plaintiffs must provide clear evidence that they were administered a qualifying Depo-Provera product and that they were diagnosed with a qualifying meningioma.
Step-by-step filing process:
- Gather your records. Collect medical records showing Depo-Provera use and your meningioma diagnosis. Include pharmacy records, insurance claims, and imaging results.
- Get a free case evaluation. Contact a product liability attorney who handles Depo-Provera claims. The consultation is free.
- Your lawyer reviews eligibility. They’ll confirm your diagnosis, duration of use, and state-specific deadlines.
- The complaint is filed. Your attorney drafts and submits the lawsuit, either into the MDL or in state court.
- Complete the MDL questionnaire. If your case enters MDL 3140, you’ll submit documentation through the centralized system.
- Wait for case progression. Your case moves through pretrial, discovery, and toward a potential settlement or trial.
Most attorneys handle Depo-Provera cases on a contingency basis. You pay nothing upfront.
What People on Reddit Are Saying About the Depo Provera Lawsuit
The Depo Provera lawsuit has generated significant discussion across Reddit communities. Real users are sharing their experiences, fears, and confusion about the litigation process.
Common themes on Reddit include women who used Depo-Provera for years and only recently learned about the meningioma link. Many express frustration that they were never warned. Others question whether their headaches or vision problems could be symptoms of an undiagnosed tumor.
Several recurring questions pop up across Reddit threads:
- “I only used Depo for two years. Do I still qualify?”
- “My meningioma was found five years ago. Is it too late?”
- “Should I get an MRI even if I have no symptoms?”
- “How do I know which law firm to trust?”
- “Are the ads I’m seeing on social media legitimate?”
These are valid concerns.The most compelling cases involve women who used Depo-Provera for five years or more. But even women with shorter-term use may be eligible, especially if the tumor required surgery or caused symptoms like vision problems, seizures, or memory loss.
The Reddit conversation reflects something important: awareness is spreading fast, but reliable information hasn’t always kept pace. That gap between awareness and understanding is exactly why clear, factual coverage matters.
Depo Provera Lawsuit Mass Tort Marketing: What to Know
Mass tort marketing campaigns for the Depo Provera lawsuit have surged across TV, social media, and search engines in 2026. These ads are designed to attract potential claimants, and they vary widely in quality and accuracy.
Not all legal marketing is equal. Some ads come from established law firms with mass tort experience. Others come from lead generation companies that collect your information and sell it to attorneys you’ve never heard of.
Here’s what you should understand about how it works. A lead generation company runs ads saying something like “Were you diagnosed with a brain tumor after Depo-Provera?” You fill out a form. Your contact details are then sold to one or more law firms.
That’s not inherently bad. But you should know the difference before you hand over personal health information.
Red flags in mass tort marketing:
- Guaranteed payout promises (no one can guarantee a settlement)
- Pressure to sign immediately
- No named attorney or law firm in the ad
- Vague or exaggerated settlement amounts
- No clear privacy policy on the form you’re filling out
Green flags:
- Named law firm with verifiable credentials
- Free case review with no obligation
- Clear explanation of the contingency fee structure
- No pressure tactics
- Transparent about the early stage of the litigation
Depo Provera Lawsuit Legal Marketing: Sorting Ads From Facts
Legal marketing for the Depo Provera lawsuit has become a billion-dollar industry, and it can be hard to separate genuine legal information from advertising. The volume of ads you see reflects how large this litigation has grown, not necessarily the quality of the firm behind the ad.
A good mass tort firm will explain the risks honestly. They’ll tell you that no settlement has been announced yet. They’ll tell you that the first trial is in December 2026. They won’t promise you a specific dollar amount.
When evaluating a law firm for your Depo-Provera case, ask these questions:
- Has the firm handled pharmaceutical mass tort cases before?
- Is the firm actually listed in the MDL leadership structure?
- What is the contingency fee percentage?
- Will the firm communicate directly with you, or hand your case to another firm?
- What happens if the case doesn’t result in a payout?
Attorneys have been appointed to one-year leadership terms in 14 committees in the Depo-Provera multidistrict litigation. Those committees set the direction for the litigation. Firms with leadership roles have the most influence over outcomes.
| Marketing Type | What to Expect |
|---|---|
| Law firm direct ads | Usually reputable; named attorney |
| Lead generation forms | Your info may be sold to multiple firms |
| Social media ads | Quality varies wildly; verify the source |
| TV commercials | Often lead generation; check the fine print |
Key Takeaway: Not all Depo-Provera lawsuit ads are created equal. Look for named firms, transparent fee structures, and honest language about the litigation’s current stage before sharing your personal information.
Frequently Asked Questions
How much is the Depo Provera lawsuit settlement per person?
No official per-person settlement has been announced yet.Lawyers estimate that individual settlement amounts could range between $100,000 and $500,000 or more, depending on individual circumstances.
Severe cases with surgery and permanent disability could see payouts of $1 million or higher.
Can I still file a Depo Provera lawsuit in 2026?
Yes, you can still file in 2026.The MDL is still accepting new cases. There should not be many statute of limitations issues in this case for women acting now.
Does Depo Provera really cause brain tumors?
The evidence is strong. A 2024 study in The BMJ found that women who used Depo-Provera for more than a year faced a 5.6 times higher risk of developing meningiomas compared to non-users. The FDA added a meningioma warning to the Depo-Provera label in December 2025.
What is the difference between the Depo Provera MDL and a class action?
With an MDL, each case is considered separately, and the individual payouts are based on the severity of the injuries in each case.
A class action applies one uniform settlement to all members. The Depo-Provera brain tumor cases are in the MDL, not a class action.
When is the first Depo Provera trial expected?
The first trial is expected to begin in December 2026.
Five pilot cases have been selected to go first. The outcome will likely shape settlement discussions for all remaining cases.
The Depo Provera lawsuit is moving fast, and 2026 is shaping up to be the most important year for this litigation. Settlement talks could begin after the bellwether trial in December.
If you used Depo-Provera and were diagnosed with a meningioma, check your eligibility now. Gather your medical records and pharmacy history. Reach out to a qualified product liability attorney before state deadlines pass.
This is your window. Don’t let it close.
